Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Harald Hovdal
Observed names:
H Hovdal,
H. Hovdal,
Harald Olav Hovdal,
Hovdal H,
Hovdal, H.
Institution:
St Olav's University Hospital
Observed institutions:
Oslo University Hospital,
University of Oslo,
Innlandet Hospital Trust,
Akershus University Hospital,
Haukeland University Hospital,
St Olav's University Hospital,
Sandoz Group AG (Switzerland),
University of Bergen
show all 8
OpenAlex ID:
A5048865414
ω-3 Fatty Acid Treatment in Multiple Sclerosis (OFAMS Study)
2012
·
Øivind Torkildsen
, Stig Wergeland
, et al.
·
Archives of Neurology
·
152
Long-term safety and efficacy of teriflunomide
2016
·
Paul O'Connor
, Giancarlo Comi
, et al.
·
Neurology
·
127
PDF
Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment
2012
·
Kristin I. Løken-Amsrud
, Trygve Holmøy
, et al.
·
Neurology
·
107
“Cervicogenic Headache”: Clinical Manifestation
1987
·
Torbjørn A Fredriksen
, Harald Hovdal
, et al.
·
Cephalalgia
·
106
Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis
2014
·
Silje Kvistad
, Kjell-Morten Myhr
, et al.
·
Multiple Sclerosis Journal
·
69
Body mass index influence interferon-beta treatment response in multiple sclerosis
2015
·
Silje Stokke Kvistad
, Kjell-Morten Myhr
, et al.
·
Journal of Neuroimmunology
·
66
Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis
2012
·
Kristin I Løken-Amsrud
, Kjell-Morten Myhr
, et al.
·
Multiple Sclerosis Journal
·
49
IL‐10 promoter haplotype influence on interferon treatment response in multiple sclerosis
2005
·
S. Wergeland
, A. Beiske
, et al.
·
European Journal of Neurology
·
45
Vitamin D, HLA ‐ DRB 1 and Epstein–Barr virus antibody levels in a prospective cohort of multiple sclerosis patients
2016
·
S. Wergeland
, K.‐M. Myhr
, et al.
·
European Journal of Neurology
·
32
Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity
2013
·
Trygve Holmøy
, Kristin Ingeleiv Løken-Amsrud
, et al.
·
PLoS ONE
·
32
PDF
No association of tobacco use and disease activity in multiple sclerosis
2016
·
Silje Kvistad
, Kjell-Morten Myhr
, et al.
·
Neurology Neuroimmunology & Neuroinflammation
·
28
PDF
Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis
2014
·
Egil Røsjø
, Kjell-Morten Myhr
, et al.
·
Journal of Neuroimmunology
·
27
Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis – Association and Prediction
2013
·
Kristin I. Løken-Amsrud
, Kjell-Morten Myhr
, et al.
·
PLoS ONE
·
27
PDF
Modelling and Prediction of 25-Hydroxyvitamin D Levels in Norwegian Relapsing-Remitting Multiple Sclerosis Patients
2012
·
J. Šaltytė Benth
, K.-M. Myhr
, et al.
·
Neuroepidemiology
·
27
PDF
Treadmill Training or Progressive Strength Training to Improve Walking in People with Multiple Sclerosis? A Randomized Parallel Group Trial
2015
·
Siri Merete Braendvik
, Teija Koret
, et al.
·
Physiotherapy Research International
·
25
α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients
2018
·
Kjetil Bjornevik
, Kjell-Morten Myhr
, et al.
·
Multiple Sclerosis Journal
·
22
Serum levels of leptin and adiponectin are not associated with disease activity or treatment response in multiple sclerosis
2018
·
Silje Stokke Kvistad
, Kjell-Morten Myhr
, et al.
·
Journal of Neuroimmunology
·
20
Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting
2018
·
Maria Trojano
, Helmut Butzkueven
, et al.
·
Multiple Sclerosis and Related Disorders
·
19
PDF
Evoked potential tests in clinical diagnosis
2013
·
Trond Sand
, Marie Bu Kvaløy
, et al.
·
Tidsskrift for Den norske legeforening
·
18
PDF
The value of dorsal column stimulation in multiple sclerosis.
1982
·
V Berg
, S Bergmann
, et al.
·
PubMed
·
18
Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis
2015
·
Egil Røsjø
, Kjell-Morten Myhr
, et al.
·
Journal of Neuroimmunology
·
16
Ergotamine in Plasma and CSF After i.m. and Rectal Administration to Humans
1982
·
Harald Hovdal
, Gaby B. Syversen
, et al.
·
Cephalalgia
·
13
Comparison of carbamazepine rash in multiple sclerosis and epilepsy
2011
·
M. Shirzadi
, S. Alvestad
, et al.
·
Acta Neurologica Scandinavica
·
10
[Optic neuritis--diagnosis, treatment and follow up].
2005
·
Rune Midgard
, Johan H Seland
, et al.
·
PubMed
·
4
Cut-off evaluation of intrathecal oligoclonal bands of IgM in relapsing-remitting multiple sclerosis; a retrospective study
2022
·
Charlotte Hvaring
, Noor Alawad
, et al.
·
Multiple Sclerosis and Related Disorders
·
3
PDF
Show more works
View as search
Works count:
36
Citation count:
1,065
H-index:
18
I10-index:
23
Year
Topic
Type